Pages that link to "Q22009065"

The following pages link to Chimeric receptors of the human C3a receptor and C5a receptor (CD88) (Q22009065):

Displaying 16 items.

• Cloning and characterization of a rabbit ortholog of human Galpha16 and mouse G(alpha)15 (Q22010833) (← links)
• The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding (Q24610523) (← links)
• Function, structure and therapeutic potential of complement C5a receptors (Q24669712) (← links)
• C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism (Q28211612) (← links)
• Remote ischemic preconditioning (RIPC) modifies the plasma proteome in children undergoing repair of tetralogy of fallot: a randomized controlled trial (Q28545220) (← links)
• Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease (Q33769083) (← links)
• The Controversial C5a Receptor C5aR2: Its Role in Health and Disease (Q33863754) (← links)
• Modulation of C5aR expression on human neutrophils by encapsulated and acapsular Cryptococcus neoformans (Q34125581) (← links)
• Sulfation of tyrosine 174 in the human C3a receptor is essential for binding of C3a anaphylatoxin (Q34215630) (← links)
• The role of the anaphylatoxins in health and disease (Q34983578) (← links)
• Sulfated tyrosines contribute to the formation of the C5a docking site of the human C5a anaphylatoxin receptor. (Q36369323) (← links)
• C4a: An Anaphylatoxin in Name Only. (Q38346764) (← links)
• Unraveling G protein-coupled receptor endocytosis pathways using real-time monitoring of agonist-promoted interaction between beta-arrestins and AP-2. (Q40098301) (← links)
• Essential role for the second extracellular loop in C5a receptor activation (Q40446589) (← links)
• Fundamental study of osteoclast chemotaxis toward chemoattractants expressed in periodontitis (Q43522018) (← links)
• The C3aR promotes macrophage infiltration and regulates ANCA production but does not affect glomerular injury in experimental anti-myeloperoxidase glomerulonephritis. (Q48284080) (← links)